← Back to patent-cliff list
CAS 1372611-82-9
Methyl exo,exo-3-(4-iodophenyl)spiro[bicyclo[3.2.1]octane-8,1'-azetidinium]-2-carboxylate
Codes：18F-FP-CIT-007
Application context (from source-drug indications)
帕金森病18F-FP-CIT
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 18F-FP-CIT18F-FP-CIT | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Methyl exo,exo-3-(4-iodophenyl)-8-(3-[[(4-methylphenyl)sulfonyl]oxy]propyl)-8-azabicyclo[3.2.1]octane-2-carboxylate→Methyl exo,exo-3-(4-iodophenyl)spiro[bicyclo[3.2.1]octane-8,1'-azetidinium]-2-carboxylate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.